1110: Kingworld Medicines Group Limited - Summary | Jitta

Kingworld Medicines Group Limited

HKG:1110

Price
HK$0.40
Loss Chance
47.5%
3.71JITTA SCORE
2.68%Under Jitta Line
Jitta Ranking
64 / 234
427 / 2,522
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (36)
Recent Business Performance (20)
Financial Strength (63)
Return to Shareholders (15)
Competitive Advantage (26)
Jitta Signs
Interest Coverage RatioGood
SG&A to SalesDecreasing
Revenue and EarningRevenue decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 67.35% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
3.71
2.68%
3.82
189.55%
Health Care Distributors
2.68
100.00%
3.93
7.64%
5.09
33.75%
COMPANY DESCRIPTION
Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution, manufacture, and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, and Kingworld Imada Red Flower Oil brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceuticals, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibitions; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities. It operates in the People’s Republic of China, France, the United States, Hong Kong, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People’s Republic of China.